Inhibition of myeloid PD-L1 suppresses osteoclastogenesis and cancer bone metastasis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of myeloid PD-L1 suppresses osteoclastogenesis and cancer bone metastasis
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-07
DOI
10.1038/s41417-022-00446-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-1 blockade inhibits osteoclast formation and murine bone cancer pain
- (2020) Kaiyuan Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer
- (2020) Brian Diskin et al. NATURE IMMUNOLOGY
- Differential regulation of breast cancer bone metastasis by PARP1 and PARP2
- (2020) Hao Zuo et al. Nature Communications
- PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade
- (2020) Qi Peng et al. Nature Communications
- PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression
- (2018) Haidong Tang et al. JOURNAL OF CLINICAL INVESTIGATION
- Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
- (2018) Heng Lin et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
- (2018) Peixin Dong et al. Frontiers in Oncology
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
- (2018) Kendall F. Moseley et al. Journal for ImmunoTherapy of Cancer
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
- (2017) Maria Gato-Cañas et al. Cell Reports
- Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication
- (2016) G. An et al. BLOOD
- B7-H1 antibodies lose antitumor activity due to activation of p38 MAPK that leads to apoptosis of tumor-reactive CD8+ T cells
- (2016) Xin Liu et al. Scientific Reports
- New therapeutic targets for cancer bone metastasis
- (2015) Jing Y. Krzeszinski et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Attenuation of TGF-β signaling supports tumor progression of a mesenchymal-like mammary tumor cell line in a syngeneic murine model
- (2013) Tanuka Biswas et al. CANCER LETTERS
- B7-H1 Expressed by Activated CD8 T Cells Is Essential for Their Survival
- (2011) V. Pulko et al. JOURNAL OF IMMUNOLOGY
- PGC1β Mediates PPARγ Activation of Osteoclastogenesis and Rosiglitazone-Induced Bone Loss
- (2010) Wei Wei et al. Cell Metabolism
- Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma
- (2009) Wendy Anne Boivin et al. LABORATORY INVESTIGATION
- The Osteoclast: Friend or Foe?
- (2008) Deborah V. Novack et al. Annual Review of Pathology-Mechanisms of Disease
- APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice
- (2008) Özge Uluçkan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
- (2008) Da Wei Huang et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started